Αρχική World News Honeybee Venom May Be the Next Treatment for Aggressive Breast Cancer

Honeybee Venom May Be the Next Treatment for Aggressive Breast Cancer

While breast cancer is often a very treatable and survivable disease, there are certain subtypes of this type of cancer that more aggressive and have fewer treatment options. These types of breast cancer tend to be more dangerous and difficult to go through.However, a new study has found a potential treatment option for people with certain types of aggressive breast cancer, including triple-negative breast cancer. And the new treatment comes from a surprising natural source.Photo: Adobe Stock/DariosDr. Ciara Duffy, from the Harry Perkins Institute of Medical Research and the University of Western Australia, conducted the research as part of her Ph.D. and published it in the journal npj Precision Oncology. She utilized venom from 312 honeybees and bumblebees from Western Australia, Ireland, and England to see if they would have any effect on certain clinical subtypes of breast cancer.Photo: Adobe Stock/KevinDr. Duffy humanely collected the bees, putting them to sleep using carbon dioxide and freezing them before removing their venom barbs for careful dissection. She then compared the different types of venom and their effects on cancer cells.The bumblebee venom proved incapable of killing cancer cells. However, the honeybee venom, particularly a component compound it contains called melittin, rapidly destroyed both triple-negative breast cancer cells and HER2-enriched breast cancer cells, regardless of what area of the world the bees were from.Photo: Adobe Stock/mirkograul“No-one had previously compared the effects of honeybee venom or melittin across all of the different subtypes of breast cancer and normal cells,” says Dr. Duffy. “We tested honeybee venom on normal breast cells and cells from the clinical subtypes of breast cancer: hormone receptor-positive, HER2-enriched, and triple-negative breast cancer.”Happily, the melittin in the venom can be reproduced synthetically in the lab, meaning that if future tests continue to show that it is effective in treating breast cancer, honeybees and bumblebees will not have to be harvested to create the medication.“The synthetic product mirrored the majority of the anti-cancer effects of honeybee venom,” says Dr. Duffy. “We found that melittin can completely destroy cancer cell membranes within 60 minutes.”Photo: Adobe Stock/sergo321So far, it appears that the honeybee venom is “extremely potent” but that a specific concentration of it can result in 100 percent cancer cell death while minimally affecting other healthy cells.Aside from its ability to kill cancer cells, melittin also had another surprising effect. Within 20 minutes, it mitigated the chemical messages that cancer cells use to grow and divide.“We looked at how honeybee venom and melittin affect the cancer signaling pathways, the chemical messages that are fundamental for cancer cell growth and reproduction, and we found that very quickly these signaling pathways were shut down,” says Dr. Duffy. “Melittin modulated the signaling in breast cancer cells by suppressing the activation of the receptor that is commonly overexpressed in triple-negative breast cancer, the epidermal growth factor receptor, and it suppressed the activation of HER2 which is over-expressed in HER2-enriched breast cancer.”Photo: Adobe Stock/IoaBalDr. Duffy also tested to see whether melittin could be combined effectively with existing breast cancer treatments. She hypothesized that when the melittin creates holes in cancer cell membranes, other medications might have easier access to their targets.And she was right. Small molecules and chemotherapies, such as docetaxel, were better able to enter the cell and kill it with the help of the melittin treatment. “The combination of melittin and docetaxel was extremely efficient in reducing tumour growth in mice,” she says.More research will be required in the future to determine optimal and maximum tolerated doses, as well as the best mode of delivery for the drug. But so far, this treatment sounds incredibly promising. It’s just one more reason why honeybees are so incredible and so worth protecting!Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ACHIEVE-2 Results of Oxaliplatin-Based Adjuvant Chemotherapy in Asian Patients with High-Risk Stage II Colon Cancer

The Asian researchers reported on 25 October 2020 in the Annals of Oncology that 3-month of combination therapy for adjuvant treatment of high-risk stage...

GreaterGood’s Mask Donations Are Helping LA Family Housing Keep Homeless People Safe

Due to the COVID-19 pandemic, people everywhere are uncertain about the future of their health, safety, and economic security. Homeless people and those who...

How I Found a Meaningful Career After Cancer

Jacky Costello is the founder and owner of a house cleaning company serving the greater Tampa Bay area in Florida. Through her company's partnership with...

Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age

October 26, 2020, by NCI Staff Radiopharmaceuticals consist of a radioactive molecule, a targeting molecule, and a linker that joins the two. Credit: National Cancer Institute The...

FDA Grants Regular Approval to Venetoclax in Combination for Untreated Acute Myeloid Leukaemia

On 16 October 2020, the US Food and Drug Administration (FDA) granted regular approval to venetoclax (VENCLEXTA ®, AbbVie Inc. and Genentech Inc.) in...

EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan

On 15 October 2020, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...